Comparison of the pros and cons of the Hong Kong version of Vigabatrin/vigabatrin and the Taiwan version of Vigabatrin

There are obvious differences in market supply and drug form between the Hong Kong version of Vigabatrin/vigabatrin and the Taiwanese version of Vigabatrin.

The Hong Kong version of Vigabatrin mainly exists in the form of the original drug. Its oral solution dispersible tablets are available in specifications:500mg*100 bags/box, and the price is about more than 1,000 yuan, but it may fluctuate due to exchange rate changes. The Hong Kong version of the original drugs has guaranteed quality, complies with international drug production standards, has undergone rigorous clinical verification in terms of efficacy and safety, and is suitable for patients with refractory partial epilepsy and infantile spasms (West syndrome). Due to the mature production process of original drugs, high drug purity and relatively controllable side effects, patients can obtain stable therapeutic effects when using them.

In contrast, there is currently no original or generic version of Vigabatrin in the Taiwan market, which means that Taiwanese patients who need to use the drug usually need to rely on imports or obtain it through other channels. This situation may affect accessibility to patients in Taiwan and may also increase purchase costs. In the absence of Taiwanese generic drugs, patients can only choose to purchase the Hong Kong version of the original drug or other overseas versions, such as Indian generic drugs. However, although the price of the Indian version of Vigabatrin is lower, due to possible quality differences between different manufacturers, patients need to be extra cautious when choosing to ensure that the drug meets safety standards.

From the perspective of clinical use, the Hong Kong version of Vigabatrin has more advantages in efficacy, solubility and bioavailability due to its original research status, which can ensure stable absorption of the drug and improve the therapeutic effect. At the same time, because it is in the form of dispersible tablets, it can be easily dissolved in liquid when taken, making it suitable for patients with swallowing difficulties or infants and young children.

Generally speaking, the Hong Kong version of Vigabatrin is more trustworthy in terms of safety, stability and efficacy. However, due to the lack of supply of this drug in the Taiwan market, patients need to weigh the purchasing channels, price and drug quality before use to ensure the smooth progress of treatment.

Reference materials:https://www.sabril.net/